Not feeling sharp? Finding it hard to concentrate? About 12-19% of adults in Australia regularly don’t get enough sleep, defined as less than 5.5-6 hours each night. But who’d have thought the amount of tree cover in their neighborhood could be a factor? Our latest research has found people with ample nearby green space are much more likely to get enough sleep than people in areas with less greenery.
Read More

People traveling into Australia will now have to self-isolate for 14 days—one of a range of measures announced at the weekend by Prime Minister Scott Morrison, with the aim of slowing the spread of the coronavirus and easing the stress on hospital beds.
Read More

Abdominal arterial (or aortic) aneurysm in older men is associated with levels of certain subtypes of white blood cells, a study from the University of Gothenburg shows. The study results belong to an expanding research field that is expected improve both knowledge of the disease and treatment options.
Read More

More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a radical idea: What if he could unlock the therapeutic potential of ancient Chinese medicines for treating cancer? What if he could design botanical drugs that would make traditional cancer treatments work better?
Read More

Amid the rise of the coronavirus pandemic, many people in the United States perceive health and economic risks and are changing their behavior. That’s according to a new survey conducted by researchers at the Center for Economic and Social Research at the USC Dornsife College of Letters, Arts and Sciences and the USC Leonard D.Schaeffer Center for Health Policy and Economics.
Read More

Mutations in the nuclear structural protein lamin A produce rare, tissue-specific diseases called laminopathies. To study these diseases, researchers from the Gasser group introduced a mutation inducing a human laminopathy in C. elegans and monitored its effect on chromatin. Not only did they understand the molecular basis of the disease, they found a way to counteract the dominant defects of the mutation, suggesting a novel therapeutic pathway.
Read More

With a vaccine for COVID-19 still a long way from being realized, Johns Hopkins immunologist Arturo Casadevall is working to revive a century-old blood-derived treatment for use in the United States in hopes of slowing the spread of the disease.
Read More

Fear is a major factor behind people’s reluctance to take part in clinical research, such as trials to test new medicines and treatments, a global review has found.
Read More

To slow the spread of COVID-19 through U.S. communities, the U.S. Centers for Disease Control and Prevention has encouraged Americans to practice “social distancing” measures. But what is social distancing, and how is it practiced?
Read More

The idea of building herd immunity—increasing the number of infected to such a degree that naturally occurring immunity would outstrip the coronavirus, while isolating the elderly and others at greatest risk of the disease—has been tossed around in the United States, the United Kingdom and elsewhere. This week, however, U.K. officials appear to be backing away from that approach.
Read More